IL-33 promotes endocrine resistance in BRCA by inducing stem cell properties27, and in addition, IL33 of fibroblast-derived origin promotes breast tumor metastasis to the lung by altering the TIME28. The gene discussed is IL33; the disease is breast neoplasm.